Intrathecal trastuzumab versus alternate routes of delivery for HER2-targeted therapies in patients with HER2+ breast cancer leptomeningeal metastases.

Lazaratos AM, Maritan SM, Quaiattini A, Darlix A, Ratosa I, Ferraro E, Griguolo G, Guarneri V, Pellerino A, Hofer S, Jacot W, Stemmler HJ, van den Broek MPH, Dobnikar N, Panet F, Lahijanian Z, Morikawa A, Seidman AD, Soffietti R, Panasci L, Petrecca K, Rose AAN, Bouganim N, Dankner M

Open source

DOI: 10.1016/j.breast.2023.04.008
Published: 2023 Jun
Container: Breast (Edinburgh, Scotland)
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.breast.2023.04.008,
  title = {Intrathecal trastuzumab versus alternate routes of delivery for HER2-targeted therapies in patients with HER2+ breast cancer leptomeningeal metastases.},
  author = {Lazaratos AM and Maritan SM and Quaiattini A and Darlix A and Ratosa I and Ferraro E and Griguolo G and Guarneri V and Pellerino A and Hofer S and Jacot W and Stemmler HJ and van den Broek MPH and Dobnikar N and Panet F and Lahijanian Z and Morikawa A and Seidman AD and Soffietti R and Panasci L and Petrecca K and Rose AAN and Bouganim N and Dankner M},
  year = {2023},
  journal = {Breast (Edinburgh, Scotland)},
  doi = {10.1016/j.breast.2023.04.008},
  url = {https://doi.org/10.1016/j.breast.2023.04.008}
}

RIS

TY  - JOUR
TI  - Intrathecal trastuzumab versus alternate routes of delivery for HER2-targeted therapies in patients with HER2+ breast cancer leptomeningeal metastases.
AU  - Lazaratos AM
AU  - Maritan SM
AU  - Quaiattini A
AU  - Darlix A
AU  - Ratosa I
AU  - Ferraro E
AU  - Griguolo G
AU  - Guarneri V
AU  - Pellerino A
AU  - Hofer S
AU  - Jacot W
AU  - Stemmler HJ
AU  - van den Broek MPH
AU  - Dobnikar N
AU  - Panet F
AU  - Lahijanian Z
AU  - Morikawa A
AU  - Seidman AD
AU  - Soffietti R
AU  - Panasci L
AU  - Petrecca K
AU  - Rose AAN
AU  - Bouganim N
AU  - Dankner M
PY  - 2023
JO  - Breast (Edinburgh, Scotland)
DO  - 10.1016/j.breast.2023.04.008
UR  - https://doi.org/10.1016/j.breast.2023.04.008
ER  -

APA

AM, L., SM, M., A, Q., A, D., I, R., E, F., G, G., V, G., A, P., S, H., W, J., HJ, S., MPH, V. D. B., N, D., F, P., Z, L., A, M., AD, S., R, S., L, P., K, P., AAN, R., N, B., & M, D. (2023). Intrathecal trastuzumab versus alternate routes of delivery for HER2-targeted therapies in patients with HER2+ breast cancer leptomeningeal metastases.. Breast (Edinburgh, Scotland). https://doi.org/10.1016/j.breast.2023.04.008

Source records

pubmed · retrieved 2026-09-26T04:02:03.960Z